National study of adverse reactions after vaccination with bacille Calmette-Guérin.
暂无分享,去创建一个
M. Gold | R. Stapledon | P. McIntyre | H. Achat | M. Burgess | F. Turnbull | H. Wang
[1] M. Hurwitz,et al. Active BCG mycobacterial infection of lymph nodes following vaccination in two paediatric patients: is surgery indicated? , 2000, The Australian and New Zealand journal of surgery.
[2] A. Bradford. The Australian Immunisation Handbook , 2000 .
[3] D. Isaacs,et al. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. , 2000, Communicable diseases intelligence.
[4] G. Gray,et al. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000. , 2000, MMWR. Morbidity and mortality weekly report.
[5] J. Grange. Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. , 1998, Communicable disease and public health.
[6] A. Altmann,et al. BCG vaccination practices in Victoria , 1996, Australian and New Zealand journal of public health.
[7] J. Puliyel,et al. Adverse local reactions from accidental BCG overdose in infants , 1996, BMJ.
[8] R. Shaw,et al. Effect of inadvertent intradermal administration of high dose percutaneous BCG vaccine , 1996, BMJ.
[9] K. Edwards,et al. Bacille Calmette-Guérin immunization in normal healthy adults. , 1994, The Journal of infectious diseases.
[10] C S Berkey,et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.
[11] L. P. Ormerod,et al. Tuberculin reactivity after neonatal percutaneous BCG immunisation. , 1993, Archives of disease in childhood.
[12] J. Fang,et al. BCG vaccination scars: incidence and acceptance amongst British high-school children. , 1993, Child: care, health and development.
[13] P. Prabhakar,et al. Outbreak of Bacillus Calmette‐Guérin‐associated lymphadenitis and abscesses in Jamaican children , 1990, The Pediatric Infectious Disease Journal.
[14] M. Gheorghiu. The present and future role of BCG vaccine in tuberculosis control. , 1990, Biologicals : journal of the International Association of Biological Standardization.
[15] J. Gibson,et al. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. , 1990, Bulletin of the World Health Organization.
[16] P. Fine,et al. BCG vaccination against tuberculosis and leprosy. , 1988, British medical bulletin.
[17] C. Helmick,et al. An outbreak of severe BCG axillary lymphadenitis in Saint Lucia, 1982-83. , 1986, The West Indian medical journal.
[18] B. Shah,et al. BACILLUS CALMETTE‐GUERIN LYMPHADENITIS: A CASE REPORT AND REVIEW OF THE LITERATURE , 1985, Pediatric infectious disease.
[19] O. Wasz‐Höckert,et al. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. , 1984, Advances in tuberculosis research. Fortschritte der Tuberkuloseforschung. Progres de l'exploration de la tuberculose.
[20] P. Lagrange,et al. Potency and suppurative adenitis in BCG vaccination. , 1978, Developments in biological standardization.
[21] R. Gorlero Bacigalupi. [BCG and tuberculosis]. , 1953, Archivos de pediatria del Uruguay.